|
State cuts part patients, counselors
Lamictal News - Boston Globe, United States - Feb 1, 2009
Through Goldfarb, Thiboult also gets prescriptions for Lamictal for his bipolar disorder, and insulin for his diabetes. Thiboult admits that he was wary the ...
GSK appoints James Murdoch as non-executive
Lamictal News - Times Online, UK - Feb 2, 2009
Patents for two high-earning products ? Imitrex for migraines and Lamictal for epilepsy ? lapsed last year. While Glaxo's spokesman would not comment on the ...
Savvy Senior
Lamictal News - Fergus Falls Daily Journal, MN - Jan 24, 2009
... ADHD drug Adderall XR (amphetamine), antiseizure drugs Topamax (topiramate) and Lamictal (lamotrigene), allergy drug Clarinex (desloratadine), ...
PNC study suggests the wealthy are 'green'
Lamictal News - Pittsburgh Post Gazette, PA - Jan 28, 2009
Mylan Inc. said it received approval from the US Food and Drug Administration to market the generic version of GlaxoSmithKline's Lamictal tablets used to ...
GSK Delivers EPS of 104.7p Before Major Restructuring
Lamictal News - PharmaLive.com (press release), PA - Feb 5, 2009
... position as the market leader in respiratory; and we are set to gain share in neurological products with the recent launch of Lamictal, for epilepsy. ...
savvy senior
Lamictal News - Seymour Herald, TN - Jan 26, 2009
... ADHD drug Adderall XR (amphetamine), antiseizure drugs Topamax (topiramate) and Lamictal (lamotrigene), allergy drug Clarinex (desloratadine), ...
Taro Pharma Gets Final FDA Approval for Lamotrigine Chewable ...
Lamictal News - RTT News, NY - Feb 5, 2009
Lamotrigine chewable tablets, marketed by GlaxoSmithKline as Lamictal CD Tablets, are a prescription pharmaceutical product used in treating seizures. by ...
KV, Novartis problems spawn drug shortage; UK starts stockpiling ...
Lamictal News - FiercePharma, DC - Jan 29, 2009
Amylin Release l Report > Mylan got the FDA nod for its versions of GlaxoSmithKline's Lamictal, used to treat epilepsy and bipolar disorder. ...
TO THE POINT
Lamictal News - Investor's Business Daily (subscription) - Jan 28, 2009
Mylan (MYL), the drugmaker, has received the FDA's OK for its generic version of the epilepsy and bipolar disorder drug Lamictal. It climbed 1.2% to 11.65. ...
 |
Pharma Deals In Offing
Lamictal News - Trading Markets (press release), CA - Feb 1, 2009
GlaxoSmithKline plc's (GSK |
Page : 1 2 3 |